Replimune Group, Inc. (REPL)
2.50
-0.07
(-2.72%)
USD |
NASDAQ |
May 01, 16:00
2.49
-0.01
(-0.40%)
After-Hours: 20:00
Replimune Group EPS Diluted (Quarterly) : -0.7694 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Bristol Myers Squibb Co. | 1.308 |
| Phathom Pharmaceuticals, Inc. | -0.3701 |
| REGENXBIO, Inc. | -1.298 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.93M |
| Total Expenses (Quarterly) | 70.93M |
| Enterprise Value | 13.64M |
| Earnings Yield | -143.3% |
| Normalized Earnings Yield | -143.30 |